Antibody ADCC May Help in Designing an Effective Vaccine for HIV

Antibody ADCC May Help in Designing an Effective Vaccine for HIVAn international team of scientists at the University of Melbourne claimed that they have discovered that how HIV-related virus evades human antibody. The new study can help in developing an effective vaccine against HIV.

The study was published in the Journal, Proceedings of the National Academy of Sciences.

The study explored the action of antibodies in HIV-infected people, which are known as ADCC. The study resulted in claiming that the HIV-related virus eludes the antibodies. The ADCC antibodies are strongly mixed up in several vaccine trials in order to protect people from HIV, but the function was not understood.

Professor Stephen Kent, who led the research asserted, "These results show what a slippery customer the HIV virus is, but also shows that these ADCC antibodies are really forcing the virus into changing, in ways that cause it to be weaker".

The study revealed that if these antibodies are available before a person gets infected with the HIV infection, it may be helpful in evading the virus. The HIV virus will not take hold in human body.

The team of scientists is now working to develop an effective HIV vaccine to induce ADCC antibodies, which will make it difficult for the virus to enter into human body. Researchers are expecting better results for the treatment of HIV infection.